DART (NCI/SWOG S1609): comprehensive final results from dual checkpoint inhibition with CTLA-4 and PD-1 blockade in rare cancers.

Patel SP, Othus M, Chae YK, Azenkot T, Alviz C, Threlkel S, Haymaker C, Streicher HZ, Magner CM, Chen HX, Sharon E, Ryan CW, Blanke CD, Kurzrock R

Open source

DOI
10.1016/j.annonc.2026.04.004
Published
2026 Aug
Container
Annals of oncology : official journal of the European Society for Medical Oncology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.annonc.2026.04.004,
  title = {DART (NCI/SWOG S1609): comprehensive final results from dual checkpoint inhibition with CTLA-4 and PD-1 blockade in rare cancers.},
  author = {Patel SP and Othus M and Chae YK and Azenkot T and Alviz C and Threlkel S and Haymaker C and Streicher HZ and Magner CM and Chen HX and Sharon E and Ryan CW and Blanke CD and Kurzrock R},
  year = {2026},
  journal = {Annals of oncology : official journal of the European Society for Medical Oncology},
  doi = {10.1016/j.annonc.2026.04.004},
  url = {https://doi.org/10.1016/j.annonc.2026.04.004}
}

RIS

TY  - JOUR
TI  - DART (NCI/SWOG S1609): comprehensive final results from dual checkpoint inhibition with CTLA-4 and PD-1 blockade in rare cancers.
AU  - Patel SP
AU  - Othus M
AU  - Chae YK
AU  - Azenkot T
AU  - Alviz C
AU  - Threlkel S
AU  - Haymaker C
AU  - Streicher HZ
AU  - Magner CM
AU  - Chen HX
AU  - Sharon E
AU  - Ryan CW
AU  - Blanke CD
AU  - Kurzrock R
PY  - 2026
JO  - Annals of oncology : official journal of the European Society for Medical Oncology
DO  - 10.1016/j.annonc.2026.04.004
UR  - https://doi.org/10.1016/j.annonc.2026.04.004
ER  - 

APA

SP, P., M, O., YK, C., T, A., C, A., S, T., C, H., HZ, S., CM, M., HX, C., E, S., CW, R., CD, B., & R, K. (2026). DART (NCI/SWOG S1609): comprehensive final results from dual checkpoint inhibition with CTLA-4 and PD-1 blockade in rare cancers.. Annals of oncology : official journal of the European Society for Medical Oncology. https://doi.org/10.1016/j.annonc.2026.04.004

Source records